Point72 Asia (Singapore)’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-10,469
Closed -$87.9K – 1186
2024
Q4
$87.9K Sell
10,469
-10,535
-50% -$81.3K 0.02% 394
2024
Q3
$166K Sell
21,004
-6,481
-24% -$58.3K 0.03% 409
2024
Q2
$283K Sell
27,485
-14,733
-35% -$160K 0.06% 234
2024
Q1
$529K Buy
42,218
+36,897
+693% +$477K 0.14% 157
2023
Q4
$81.6K Buy
+5,321
New +$74.4K 0.02% 239

Other funds holding TBI

Point72 Asia (Singapore)'s TBI Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of Trueblue (TBI) in Q1 2025, closing a stake of 10,469 shares — an estimated $87.9K sold.

Point72 Asia (Singapore) first reported a position in TBI in Q4 2023 and held it in 5 quarters. The position peaked at $529K in Q1 2024. 111 funds tracked by Wall St. Rank hold TBI as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining Trueblue position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 10,469 Trueblue shares in Q1 2025, an estimated $87.9K.
  • Point72 Asia (Singapore) first reported a position in Trueblue in Q4 2023 and held it in 5 quarters.
  • Point72 Asia (Singapore)'s Trueblue position peaked at $529K in Q1 2024.
  • 111 funds tracked by Wall St. Rank held Trueblue as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.